Acetylation of MyoD by p300 requires more than its histone acetyltransferase domain

Citation
A. Polesskaya et A. Harel-bellan, Acetylation of MyoD by p300 requires more than its histone acetyltransferase domain, J BIOL CHEM, 276(48), 2001, pp. 44502-44503
Citations number
17
Categorie Soggetti
Biochemistry & Biophysics
Journal title
JOURNAL OF BIOLOGICAL CHEMISTRY
ISSN journal
00219258 → ACNP
Volume
276
Issue
48
Year of publication
2001
Pages
44502 - 44503
Database
ISI
SICI code
0021-9258(20011130)276:48<44502:AOMBPR>2.0.ZU;2-A
Abstract
MyoD, an essential transcription factor involved in muscle cell terminal di fferentiation, is regulated by acetylation, as are a number of other transc ription factors, but the histone acetyltransferase enzyme responsible for t his acetylation is a matter of controversy. In particular, contradictory fi ndings have been reported concerning the ability of CBP/p300 to acetylate M yoD in vitro. Here we provide an explanation for this discrepancy: although full-length p300 does indeed acetylate MyoD, a fragment of p300 correspond ing to its histone acetyltransferase domain does not. In addition to clearl y demonstrating that p300 acetylates MyoD in vitro, these results underscor e the necessity of using full-length histone acetyltransferase enzymes to d raw valid conclusions from acetylation experiments.